Microangiopathic haemolytic anaemia and hyposplenism in angiosarcoma
Daunorubicin-induced hyperpigmentation
Risk stratification of normotensive patients with acute symptomatic pulmonary embolism
One hundred years of sickle cell disease
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia
Immunogenetics features and genomic lesions in splenic marginal zone lymphoma
Molecular characterization of paediatric idiopathic hypereosinophilia
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984–2003
Genetic typing of CBL , ASXL1 , RUNX1 , TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia
The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation
Autologous 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry
Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura
Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy
Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia
Desensitization to hydroxycarbamide following long-term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers
Extramedullary plasmacytoma are characterized by a ‘myeloma-like’ immunophenotype and genotype and occult bone marrow involvement
Childhood B-cell precursor acute lymphoblastic leukaemia in a patient with familial thrombocytopenia and RUNX1 mutation
Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma